Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Liew

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Haematologica|May 25, 2011
Familial myelodysplastic syndromes: a review of the literatureElena Liew, Carolyn Owen
Clinical Lymphoma, Myeloma & Leukemia|November 22, 2025
Proposed Modifications to Prognostic Classification of AML Patients Treated With Intensive Chemotherapy Based on Recent Real-World DataJoseph Brandwein, David Page, Elena Liew, et al.
Leukemia Research|November 9, 2013
Quality of life following completion of treatment for adult acute lymphoblastic leukemia with a pediatric-based protocolElena Liew, Santhosh Thyagu, Eshetu G Atenafu, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 1, 2025
A Real-World Evaluation of Frontline Treatment for Acute Myeloid Leukemia With Azacitidine Plus VenetoclaxJoseph Brandwein, David Page, Elena Liew, et al.
Leukemia Research|July 19, 2023
Changing frontline AML treatment patterns from 2013 to 2022Joseph M Brandwein, Kurt Ebeling, Lei Ding, et al.
Leukemia Research|August 1, 2021
Clinical outcome of chronic myeloid leukemia patients who switch from first-line therapy with a second generation tyrosine kinase inhibitor to an alternative TKIChen-En Ma, Sunita Ghosh, Catherine Leyshon, et al.
Leukemia Research|September 4, 2012
Outcomes of adult patients with relapsed acute lymphoblastic leukemia following frontline treatment with a pediatric regimenElena Liew, Eshetu G Atenafu, Aaron D Schimmer, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 5, 2015
Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms GroupShireen Sirhan, Lambert Busque, Lynda Foltz, et al.
European Journal of Haematology|March 31, 2016
The fludarabine, cytarabine, and granulocyte colony-stimulating factor (FLAG) chemotherapy regimen is an alternative to anthracycline-based therapy for the treatment of acute myeloid leukemia for patients with pre-existing cardiac diseaseLalit Saini, Joseph Brandwein, Robert Turner, et al.
Leukemia Research|April 20, 2016
Incremental value of the bone marrow trephine biopsy in detecting residual leukemia following treatment for Acute Myeloid LeukemiaLalit Saini, Joseph Brandwein, Robert Turner, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Haematologica|May 25, 2011
Familial myelodysplastic syndromes: a review of the literatureElena Liew, Carolyn Owen
Clinical Lymphoma, Myeloma & Leukemia|November 22, 2025
Proposed Modifications to Prognostic Classification of AML Patients Treated With Intensive Chemotherapy Based on Recent Real-World DataJoseph Brandwein, David Page, Elena Liew, et al.
Leukemia Research|November 9, 2013
Quality of life following completion of treatment for adult acute lymphoblastic leukemia with a pediatric-based protocolElena Liew, Santhosh Thyagu, Eshetu G Atenafu, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 1, 2025
A Real-World Evaluation of Frontline Treatment for Acute Myeloid Leukemia With Azacitidine Plus VenetoclaxJoseph Brandwein, David Page, Elena Liew, et al.
Leukemia Research|July 19, 2023
Changing frontline AML treatment patterns from 2013 to 2022Joseph M Brandwein, Kurt Ebeling, Lei Ding, et al.
Leukemia Research|August 1, 2021
Clinical outcome of chronic myeloid leukemia patients who switch from first-line therapy with a second generation tyrosine kinase inhibitor to an alternative TKIChen-En Ma, Sunita Ghosh, Catherine Leyshon, et al.
Leukemia Research|September 4, 2012
Outcomes of adult patients with relapsed acute lymphoblastic leukemia following frontline treatment with a pediatric regimenElena Liew, Eshetu G Atenafu, Aaron D Schimmer, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 5, 2015
Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms GroupShireen Sirhan, Lambert Busque, Lynda Foltz, et al.
European Journal of Haematology|March 31, 2016
The fludarabine, cytarabine, and granulocyte colony-stimulating factor (FLAG) chemotherapy regimen is an alternative to anthracycline-based therapy for the treatment of acute myeloid leukemia for patients with pre-existing cardiac diseaseLalit Saini, Joseph Brandwein, Robert Turner, et al.
Leukemia Research|April 20, 2016
Incremental value of the bone marrow trephine biopsy in detecting residual leukemia following treatment for Acute Myeloid LeukemiaLalit Saini, Joseph Brandwein, Robert Turner, et al.
Pageof 2